Abevmy 100mg Injection

About

Abevmy 100mg Injection is a recombinant humanized monoclonal antibody designed to specifically target and neutralize vascular endothelial growth factor (VEGF). VEGF plays a critical role in angiogenesis, the process of new blood vessel formation essential for tumor growth and spread. By binding to VEGF, Abevmy prevents it from interacting with its receptors on endothelial cells, thereby inhibiting the development of new blood vessels that supply tumors.

This action starves the tumor of oxygen and nutrients, leading to reduced tumor growth and metastasis. It is used in combination with various chemotherapies for the treatment of several advanced cancers, providing a targeted approach to disrupt tumor progression and improve patient outcomes.

Uses

• Treatment of metastatic colorectal cancer.
• Management of non-small cell lung cancer.
• Therapy for glioblastoma multiforme.
• Treatment of metastatic renal cell carcinoma.

Directions For Use

Administer intravenously under the supervision of a healthcare professional. The dosage and frequency will be determined by your doctor based on your condition.

Benefits

• Inhibits tumor growth and metastasis.
• Prolongs progression-free survival in various cancers.
• Improves overall survival when combined with chemotherapy.
• Reduces tumor vascularization.
• Offers a targeted therapy approach.
• Effective across multiple cancer types.

Side Effects

• Hypertension (high blood pressure)
• Proteinuria (protein in urine)
• Fatigue
• Diarrhea
• Nausea
• Abdominal pain
• Headache
• Bleeding events
• Thromboembolic events
• Gastrointestinal perforation (rare)
• Wound healing complications
• Infusion-related reactions

Safety Measures

• Alcohol - No direct interaction, but alcohol should be consumed in moderation, especially if experiencing fatigue or gastrointestinal side effects.
• Pregnancy - Contraindicated during pregnancy due to potential fetal harm and teratogenicity. Effective contraception is required.
• Breastfeeding - Avoid during breastfeeding as the drug may pass into breast milk and cause serious adverse effects in the infant.
• Liver - Use with caution in patients with liver impairment; no specific dose adjustment guidelines, but monitor closely.
• Kidney - Use with caution in patients with kidney impairment; monitor for proteinuria and renal function.
• Lung - Use with caution in patients with a history of hemoptysis or lung hemorrhage due to increased bleeding risk.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.